OKUR vs RMD · P/E 72, rev $2.0M vs P/E 29, rev $5.65B
OnKure Therapeutics, Inc. (OKUR) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the OKUR and RMD stock pages for the full models.
Not investment advice.